Use access key #2 to skip to page content.
$10.70 -0.72 (-6.30%)
11/21/2008 4:00 PM

ISIS Pharmaceuticals, Inc. (ISIS)

CAPS Rating:
***

The Company is a biopharmaceutical company exploiting proprietary RNA-based drug discovery technologies to create a new class of drugs to treat important diseases.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating ISIS

Add Stock to Watchlist

What the Community Thinks

Total Members

440 Outperforms
27 Underperforms
 

All-Stars

74 Outperforms
10 Underperforms
 

Wall Street

10 Outperforms
0 Underperforms
 

Members bullish on ISIS are also bullish on:

Members bearish on ISIS are also bearish on:

Ticker Tags

Rule Breakers Universe (137), Small Cap (1354), Biotechnology (230)
Suggest a tag

ISIS Pharmaceuticals, Inc. At A Glance

Current Price: $10.70
Last Trade Time: 11/21/2008 4:00 PM
Open: $11.76
Previous Close: $11.42
Daily Range: $10.24 - $11.76
52-Week Range: $10.91 - $20.15
Volume: 2,158,255
Market Cap: $1.11B
P/E Ratio: 0.00
Compare Our Special Broker Offers!

Stock Trends

ISIS VS S&P 500 (SPY)

News & Discussion Boards

Other News Headlines for ISIS

More Headlines...

Top Bull Pitch

Recs

4

ISIS Pharmaceuticals, Inc. (ISIS)

Avatar SaintCroix (25.54) Submitted: 11/26/07 10:39 AM

I'm re-upping on this, my favorite biotech. Isis is the antisense pure-play. Read this article to see why I'm excited about antisense:





http://www.signalsmag.com/signalsmag.nsf/CA8B17DF522401B78825651B007CDA00/DEC8F66F64983B10882569CA00785D5C?OpenDocument



More

Replies: 0 | Reply | Permalink

Top Bear Pitch

Recs

1

ISIS Pharmaceuticals, Inc. (ISIS)

Avatar synergize (99.68) Submitted: 5/14/08 11:58 PM

Please use the daily charts before you read farther to understand what I mean.

Most of the time when the price of this stock gaps up, it goes down. Its noticeable gap up was on 8-Jan-2008 only to go down for several weeks. The investors of this stock are using those gaps up as their exit points by ...More

Replies: 1 | Reply | Permalink

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 101 :   1 2 3 4 5 Next » Jump to page:

Recs

0

 (ISIS)

Avatar BruceInCola (33.49) Submitted: 11/06/08 11:42 AM : Outperform Start Price: $16.57 ISIS Score: 2.22

$22

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (ISIS)

Avatar GuitarFool69 (74.22) Submitted: 10/22/08 12:48 PM : Outperform Start Price: $13.69 ISIS Score: -3.77

RNA drugs are the coming thing - It would be nice to see if they have drugs soon in stage two testing. More research is needed on this company in my opinion. I am giving them an out perform due to potential in their products and the technology.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (ISIS)

Avatar SecretCzar (44.27) Submitted: 10/11/08 6:55 PM : Outperform Start Price: $12.75 ISIS Score: 3.65

Mixed emotions on this one since all Income relies on license agreements, contracts, government grants (i.e., prefer cash and consumer staples at such times). Possibly a bad call if we truly enter a recession - regardless of how much "...is in the pipe line". Not for the faint of heart. I sold out myself. In the near term, stock will trade in an active range and likely end up higher. If times get tough, however, this could rapidly change (for the worse). Still, if the economy improves, could be a great value.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (ISIS)

Avatar DollarDoomProfit (< 20) Submitted: 9/29/08 12:45 PM : Outperform Start Price: $16.50 ISIS Score: -0.11

Best RNA tech. Huge investments from major pharms already.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (ISIS)

Avatar CRAMERSUKS (57.47) Submitted: 8/29/08 6:12 PM : Underperform Start Price: $17.94 ISIS Score: -1.36

My purpose and purpose only is to pick the opposite of whatever Jim Cramer picks to prove a point......

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 101 :   1 2 3 4 5 Next » Jump to page:

Wall Street

Results 1 - 10 of 10  

picks per page. CHANGE Expand All Pitches

Top
Pick
Member NameMember RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackZacks 77.13 11/11/08 Outperform 3M $15.12-29.23%-15.52%-13.71 Toggle the visibility of 60-Second Pitch and replies
TrackJimCramer 85.65 08/27/08 Outperform 3W $17.73-39.65%-41.04%+1.39
TrackWachovia < 20 10/11/07 Outperform NS $16.02-33.21%-51.68%+18.47
TrackJefferies < 20 07/19/07 Outperform NS $11.33-5.56%-51.14%+45.58
TrackNeedham < 20 07/09/07 Outperform NS $10.60+0.94%-50.49%+51.43
TrackTobinSmith < 20 06/22/07 Outperform 1Y $9.53+12.28%-49.64%+61.92
TrackFortisBank 96.93 03/20/07 Outperform NS $8.93+19.82%-45.97%+65.79
TrackLehmanBros < 20 01/29/07 Outperform NS $11.06-3.25%-46.67%+43.41
TrackAGEdwards 87.66 11/10/06 Outperform NS $10.37+3.18%-45.10%+48.29
TrackCowenandCo 78.45 11/09/06 Outperform NS $10.19+5.00%-45.45%+50.46

Results 1 - 10 of 10  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners

Sponsored Links